August 30, 2023 — Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with 

August 30, 2023 — “Joining forces to protect the heart – this was our mission for this year’s ESC Congress,” said Professor Franz Weidinger, ESC President. “Cardiovascular (CV) medicine has been tremendously successful in improving and even prolonging life through paramount achievements over the last decades. Now it’s time to make sure that all of our patients who need treatment do get it – timely, effectively, sustainably. This is why we need to join forces as CV professionals, industry, policymakers, and patients.” 

August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according

August 29, 2023 — The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online in European Heart Journal.1 The document covers the man

SCCT Global 2024 Budapest

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate therapy for prevention of sudden cardiac death? The PROFID EHRA trial is set to answer this question in a large, multicenter, EU-funded study set to enroll the first patient this summer.

August 28, 2023 — Ferric carboxymaltose(FCM) did not improve a hierarchical outcome of death, heart failure hospitalizations and exercise function in ambulatory patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency, according to late brea

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable cardioverter-defibrillator (ICD) in select patients with heart failure and reduced ejection fraction (HFrEF) and intermittent or permanent right ventricular (RV) pacing, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.1 

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for cardiovascular events in patients with acute coronary syndrome (ACS) or high bleeding risk (HBR), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.1 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now